Biotech Values

[ghmm]

PDLI:

I am not surprised to see the stock down in AH. Royalty companies generally attract some investors who seek out a dividend. Successful ones tend to have a small dividend and raise cash opportunistically. I passed on PDL a long time ago because of the whole patent issue with Genentech (I thought it too risky to call) and their dependence on it was too much. I never got a sense that management was particularly astute to do royalties more that they needed a new business model. Don't know if that was fair but that kept me out and haven't followed them since.